KUCHING, 10 Dis (Bernama) – Suruhanjaya Pencegahan Rasuah Malaysia (SPRM) Sarawak telah membentangkan sebanyak 14 syor penambahbaikan tatakelola kepada pengurusan Institusi Pengajian Islam ...
A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...
AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback